BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26925822)

  • 61. Systemic cyclosporin A in severe atopic keratoconjunctivitis.
    Cornish KS; Gregory ME; Ramaesh K
    Eur J Ophthalmol; 2010; 20(5):844-51. PubMed ID: 20491051
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Methotrexate for treatment of atopic dermatitis in children and adolescents.
    Deo M; Yung A; Hill S; Rademaker M
    Int J Dermatol; 2014 Aug; 53(8):1037-41. PubMed ID: 24602088
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Commentary: Methotrexate and ciclosporin in the treatment of severe eczema in children.
    Irvine AD
    Br J Dermatol; 2014 Mar; 170(3):499-500. PubMed ID: 24617433
    [No Abstract]   [Full Text] [Related]  

  • 64. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
    Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
    Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.
    Haeck IM; Knol MJ; Ten Berge O; van Velsen SG; de Bruin-Weller MS; Bruijnzeel-Koomen CA
    J Am Acad Dermatol; 2011 Jun; 64(6):1074-84. PubMed ID: 21458107
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.
    Berth-Jones J; Takwale A; Tan E; Barclay G; Agarwal S; Ahmed I; Hotchkiss K; Graham-Brown RA
    Br J Dermatol; 2002 Aug; 147(2):324-30. PubMed ID: 12174106
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
    Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC
    J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Azatropin in severe atopic dermatitis: 24 cases].
    Malthieu F; Guillet G; Larregue M
    Ann Dermatol Venereol; 2005 Feb; 132(2):168-70. PubMed ID: 15798572
    [No Abstract]   [Full Text] [Related]  

  • 69. [How should severe and chronic atopic dermatitis be managed in children?].
    Bernier C
    Ann Dermatol Venereol; 2005 Jan; 132 Spec No 1():1S267-81. PubMed ID: 15984312
    [No Abstract]   [Full Text] [Related]  

  • 70. Systemic therapeutic options for severe atopic dermatitis.
    BuBmann C; Bieber T; Novak N
    J Dtsch Dermatol Ges; 2009 Mar; 7(3):205-19. PubMed ID: 18759739
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The methotrexate polyglutamate assay supports the efficacy of methotrexate for severe inflammatory skin disease in children.
    Rahman SI; Siegfried E; Flanagan KH; Armbrecht ES
    J Am Acad Dermatol; 2014 Feb; 70(2):252-6. PubMed ID: 24332314
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life.
    Czech W; Bräutigam M; Weidinger G; Schöpf E
    J Am Acad Dermatol; 2000 Apr; 42(4):653-9. PubMed ID: 10727313
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cyclosporin in atopic dermatitis: review of the literature and outline of a Belgian consensus.
    Naeyaert JM; Lachapelle JM; Degreef H; de la Brassinne M; Heenen M; Lambert J
    Dermatology; 1999; 198(2):145-52. PubMed ID: 10325461
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
    N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study.
    Lee SS; Tan AW; Giam YC
    Ann Acad Med Singap; 2004 May; 33(3):311-3. PubMed ID: 15175770
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outcome of treatment with azathioprine in severe atopic dermatitis: a 5-year retrospective study of adult outpatients.
    Thomsen SF; Karlsmark T; Clemmensen KK; Graversgaard C; Ibler KS; Jemec GB; Agner T
    Br J Dermatol; 2015 Apr; 172(4):1122-4. PubMed ID: 25350702
    [No Abstract]   [Full Text] [Related]  

  • 77. Systemic Agents for Severe Atopic Dermatitis in Children.
    Notaro ER; Sidbury R
    Paediatr Drugs; 2015 Dec; 17(6):449-57. PubMed ID: 26547214
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Refractory atopic dermatitis treated with low dose cyclosporin.
    Yu FC; Gibbon GW; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):127-31. PubMed ID: 12197567
    [No Abstract]   [Full Text] [Related]  

  • 79. Successful treatment of severe atopic dermatitis with methotrexate.
    Balasubramaniam P; Ilchyshyn A
    Clin Exp Dermatol; 2005 Jul; 30(4):436-7. PubMed ID: 15953091
    [No Abstract]   [Full Text] [Related]  

  • 80. [Cyclosporin in atopic dermatitis].
    Pacor ML; Biasi D; Di Lorenzo G; Carletto A; Corrocher R
    Recenti Prog Med; 2001 Jun; 92(6):390-1. PubMed ID: 11433717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.